Percutaneous Coronary Intervention for Cardiogenic Shock in the SHOCK Trial

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1380-1386

  Webb, John G ^a   Lowe, April M ^b   Sanborn, Timothy A ^c   White, Harvey D ^d   Sleeper, Lynn A ^b   Carere, Ronald G ^a   Buller, Christopher E ^e   Wong, S Chiu ^f   Boland, Jean ^g   Dzavik, Vlad ^h   Porway, Mark ⁱ   Pate, Gordon ^a   Bergman, Geoffrey ^f   Hochman, Judith S ^j  

^a ST PAUL S HOSPITAL   (Canada)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^d GREEN LANE HOSPITAL   (New Zealand)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f New York Presbyterian Medical Center   (United States)

^g Centre Hospitalier Regional de La Citadelle   (Belgium)

^h TORONTO GENERAL HOSPITAL   (Canada)

ⁱ BAYSTATE MEDICAL CENTER   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BIOAVAILABILITY; BYPASS SURGERY; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; HEART INFARCTION; HUMAN; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

EID: 10744221296     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01050-7     Document Type: Article

References (25)

1. Antoniucci D, Valenti R, Santoro G, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
2. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995;91:873-91.
3. Webb JG, Hochman JS. Pathophysiology and management of cardiogenic shock due to primary pump failure. In: Ghersh B, Rahimtoola S, editors. Acute Myocardial Infarction. New York, NY: Chapman & Hall, 1997:308-27.
4. Webb JG. Interventional management of cardiogenic shock. Can J Cardiol 1998;14:233-44.
5. Perez-Castellano N, Garcia E, Serrano J, et al. Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 1999;83:989-93.
6. Hochman JS, Sleeper LA, White H, et al. One year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-2.
7. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-34.
8. Hochman JS, Sleeper LA, Godfrey E, et al. Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABG. Am Heart J 1999;137:313-21.
9. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
10. Califf RM, Phillips HR, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985;5:1055-63.
11. Ryan TJ, Faxon DP, Gunnary RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1998;12:529-45.
12. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990;82:1193-202.
13. Sheehan FH. Cardiac angiography. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, editors. Cardiac Imaging. Philadelphia, PA: WB Saunders, 1991:109-48.
14. Webb JG, Sanborn T, Sleeper LA, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J 2001;141:964-70.
15. Berger P, Holmes D, Stebbins A, Bates E, Califf R, Topol E. Impact of an aggressive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Coronary Arteries (GUSTO-1) Trial. J Am Coll Cardiol 1997;96:122-7.
16. Bates E, Topol E. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991;18:1077-84.
17. Chan A, Chew D, Bhatt D, Moliterno D, Topol E, Ellis S. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002;89:132-6.
18. Giri S, Mitchel J, Azar R, et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002;89:126-31.
19. Hasdai S, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2002;36:685-92.
20. Stone GW, Grines CL, Cox DA, et al. The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction, N Engl J Med 2002;346:957-66.
21. Cotter G, Kaluski E, Blatt A, et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 2000;101:1358-61.
22. Webb JG, Sleeper LA, Buller C, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK registry. J Am Coll Cardiol 2000,36:1084-90.
23. Thompson CR, Buller C, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000;36:1102-9.
24. Dzavik V, Sleeper L, Cocke TP, et al. Early revascularization in associated with improved survival in elderly patients with acute myocardial infarction complicated with cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 2003;24:828-37.
25. Webb JG, Carere R, Hilton JD, et al. Usefulness of coronary stenting in cardiogenic shock. Am J Cardiol 1997;79:81-4.